Takaaki Tokito Selected Research

Interstitial Lung Diseases (Interstitial Lung Disease)

10/2023	Survival and soluble immune mediators of immune checkpoint inhibitor-induced interstitial lung disease in patients with non-small cell lung cancer.
4/2023	Multicenter, single-arm phase II study of modified carboplatin/nab-paclitaxel in untreated performance status 2 patients with advanced non-small cell lung cancer: TORG1426.
1/2023	Clinical significance of interstitial lung abnormalities and immune checkpoint inhibitor-induced interstitial lung disease in patients with non-small cell lung cancer.
12/2020	A Phase 2 Study of Atezolizumab for Pretreated NSCLC With Idiopathic Interstitial Pneumonitis.
12/2020	Osimertinib for patients with poor performance status and EGFR T790M mutation-positive advanced non-small cell lung cancer: a phase II clinical trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takaaki Tokito Research Topics

Disease

45	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 06/2013
21	Neoplasms (Cancer) 10/2023 - 06/2013
7	Pneumonia (Pneumonitis) 04/2024 - 11/2017
7	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2024 - 03/2010
7	Disease Progression 01/2023 - 09/2016
6	Lung Neoplasms (Lung Cancer) 04/2024 - 09/2016
5	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2023 - 12/2020
5	Neoplasm Metastasis (Metastasis) 12/2020 - 03/2010
3	Adenocarcinoma of Lung 10/2022 - 10/2015
3	Adenocarcinoma 12/2020 - 01/2018
2	Cytokine Release Syndrome 11/2023 - 10/2022
2	Fever (Fevers) 11/2023 - 10/2022
2	Cachexia 10/2023 - 01/2023
2	Infections 10/2022 - 05/2014
2	Diarrhea 10/2022 - 01/2021
2	Stomach Neoplasms (Stomach Cancer) 12/2020 - 12/2019
2	Neutropenia 12/2019 - 03/2014
2	Body Weight (Weight, Body) 12/2018 - 11/2017
1	Idiopathic Pulmonary Fibrosis 02/2024
1	Febrile Neutropenia 10/2023
1	Adenoid Cystic Carcinoma (Cylindroma) 10/2023
1	Peripheral Nervous System Diseases (PNS Diseases) 04/2023
1	Cysts 01/2023
1	Bronchiectasis 01/2023
1	Dyspnea (Shortness of Breath) 11/2022
1	Rhabdomyosarcoma 11/2022
1	COVID-19 10/2022
1	Heart Arrest (Cardiac Arrest) 10/2022
1	Idiopathic Interstitial Pneumonias 01/2022
1	Colitis 08/2018
1	Aplastic Anemia (Anemia, Hypoplastic) 10/2017
1	Pancytopenia 10/2017
1	Gastrointestinal Hemorrhage (Hematochezia) 10/2015
1	Ulcerative Colitis 10/2015

Drug/Important Bio-Agent (IBA)

13	Immune Checkpoint InhibitorsIBA 10/2023 - 08/2018
11	PlatinumIBA 02/2024 - 06/2013
8	Carboplatin (JM8)FDA LinkGeneric 04/2024 - 10/2015
8	Pemetrexed (MTA)FDA Link 01/2023 - 03/2014
7	ErbB Receptors (EGF Receptor)IBA 04/2024 - 01/2018
5	Tyrosine Kinase InhibitorsIBA 04/2024 - 01/2018
5	NivolumabIBA 04/2024 - 08/2018
5	Etoposide (VP 16)FDA LinkGeneric 04/2024 - 02/2014
5	pembrolizumabIBA 02/2024 - 01/2021
5	AfatinibIBA 01/2023 - 01/2018
5	Bevacizumab (Avastin)FDA Link 01/2021 - 06/2013
4	osimertinibIBA 04/2024 - 01/2020
4	durvalumabIBA 04/2024 - 11/2017
3	IpilimumabIBA 04/2024 - 10/2022
3	RamucirumabIBA 10/2023 - 12/2019
3	Docetaxel (Taxotere)FDA Link 10/2023 - 12/2018
3	130-nm albumin-bound paclitaxelIBA 04/2023 - 01/2020
3	atezolizumabIBA 01/2022 - 12/2020
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2018 - 03/2010
3	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 03/2014
3	LigandsIBA 09/2017 - 03/2015
2	Biomarkers (Surrogate Marker)IBA 12/2023 - 10/2023
2	SolutionsIBA 03/2022 - 01/2020
2	B7-H1 AntigenIBA 01/2021 - 11/2017
2	Programmed Cell Death 1 ReceptorIBA 01/2021 - 03/2015
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021 - 01/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2015 - 06/2013
1	tepotinibIBA 02/2024
1	nintedanibIBA 02/2024
1	C-Reactive ProteinIBA 10/2023
1	GhrelinIBA 10/2023
1	OsteopontinIBA 10/2023
1	CytokinesIBA 01/2023
1	pazopanib FDA Link 11/2022
1	eribulin FDA Link 11/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2022
1	Amino Acids FDA Link 01/2022
1	Tryptophan (L-Tryptophan)FDA Link 01/2022
1	amrubicinIBA 01/2021
1	Circulating Tumor DNAIBA 01/2020
1	Adenosine Monophosphate (AMP)IBA 01/2020
1	Adenosine (Adenocard)FDA LinkGeneric 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2019
1	Tumor Biomarkers (Tumor Markers)IBA 05/2019
1	Carcinoembryonic AntigenIBA 05/2019
1	Keratins (Keratin)IBA 05/2019
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 10/2015
1	Monoclonal AntibodiesIBA 10/2015

Therapy/Procedure

23	Drug Therapy (Chemotherapy) 02/2024 - 03/2010
15	Therapeutics 04/2024 - 06/2013
6	Chemoradiotherapy 04/2024 - 03/2016
6	Aftercare (After-Treatment) 11/2023 - 10/2015
4	Immunotherapy 10/2023 - 10/2022
2	Lymph Node Excision (Lymph Node Dissection) 12/2020 - 12/2019
2	Gastrectomy 12/2020 - 12/2019
1	Proton Therapy 10/2023
1	Traction 01/2023
1	Critical Care (Surgical Intensive Care) 10/2022
1	Hepatectomy 12/2020
1	Gastroenterostomy 12/2020
1	Withholding Treatment 12/2020
1	Radiotherapy 11/2017
1	Adjuvant Chemotherapy 09/2017
1	Bronchoscopes 01/2017
1	Duration of Therapy 11/2016